Iprivask available for prevention of deep vein thrombosis - MPR

Links shared publicly online about this topic.

1,346
total visits

Iprivask available for prevention of deep vein thrombosis - MPR

Canyon Pharmaceuticals announced that Iprivask (desirudin for injection), a direct thrombin inhibitor, has been made available for the prevention of deep vein thrombosis (DVT), which may lead to pulmonary embolism, in patients undergoing elective hip replacement surgery.

View full resource at empr.com

Tags: Circulation, Circulatory Disorders, Deep Venous Thrombosis, Pulmonary Embolism, Thrombotic Event, Pharma, Pulmonology

Most Recently Shared on March 1, 2010 at 9:28 pm By:

MPR

MPR News: Iprivask available for prevention of deep vein thrombosis: Canyon Pharmaceuticals announced that Iprivas... http://bit.ly/9YDWcG

2 years ago...

Retweet

Favorite

Iprivask available for prevention of deep vein thrombosis - ONA

oncologynurseadvisor.com — “Canyon Pharmaceuticals announced that Iprivask (desirudin for injection), a direct thrombin inhibitor, has been made available for the prevention of deep vein thrombosis (DVT), which may lead to pulmonary embolism, in patients undergoing elective hip replacement surgery.” View full resource at oncologynurseadvisor.com